Clinical Trial Update: Effect of Dapagliflozin on LV Remodeling Post AMI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating the effect of dapagliflozin on left ventricular remodeling after myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Myocardial Infarction

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN